Bone Mineral Accrual Is Associated With Parathyroid Hormone and 1,25-Dihydroxyvitamin D Levels in Children and Adolescents

被引:12
作者
DeBoer, Mark D. [1 ]
Weber, David R. [2 ]
Zemel, Babette S. [3 ]
Denburg, Michelle R. [3 ]
Herskovitz, Rita [3 ]
Long, Jin [3 ]
Leonard, Mary B. [4 ,5 ]
机构
[1] Univ Virginia, Dept Pediat, Charlottesville, VA 22908 USA
[2] Univ Rochester, Dept Pediat, Rochester, NY 14642 USA
[3] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA
[4] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA
[5] Stanford Univ, Dept Med, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
VITAMIN-D; CORTICAL BONE; SEXUAL-DIMORPHISM; HEALTHY-CHILDREN; ALPHA THERAPY; DENSITY; CALCIUM; HYPERPARATHYROIDISM; REPLACEMENT; METABOLISM;
D O I
10.1210/jc.2015-1637
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Rapid bone accrual and calcium demands during puberty may result in compensatory increases in PTH and 1,25-dihydroxyvitamin D [1,25(OH)(2)D] levels; however, these relations have not been established in longitudinal studies. Objective: To determine whether greater bone accrual velocity is associated with greater PTH and 1,25(OH)(2)D levels in healthy children and adolescents. Design: Prospective cohort study with baseline PTH, 25-hydroxyvitamin D [25(OH)D], and 1,25(OH)(2)D levels and dual-energy x-ray absorptiometry whole-body bone mineral content (BMC) accrual over 12 months. Secondary analyses examined bone biomarkers and tibia quantitative computed tomography midshaft cortical-BMC. Participants: A total of 594 healthy participants, ages 5-21 years, with longitudinal measures in a subset of 145 participants. Main Outcome Measures: PTH and 1,25(OH)(2)D levels. Results: PTH levels were higher during Tanner stages 3 and 4 compared to Tanner 1 (P < .05) in males and females and were inversely and significantly associated with 25(OH)D levels and dietary calcium intake. In multivariable analyses, greater bone accrual [measured directly as change in dual-energy x-ray absorptiometry-BMC (P < .001) or quantitative computed tomography-BMC (P < .05), or indirectly as growth velocity (P < .05) or greater bone-formation biomarker level (P < .01)] was associated with higher PTH levels, independent of 25(OH)D level and dietary calcium intake. Similar associations were observed between these direct and indirect indices of bone accrual and 1,25(OH)(2)D levels. Conclusions: PTH levels rise in midpuberty, in association with multiple measures of bone accrual. This is consistent with compensatory increases in PTH to drive 1,25(OH)(2)D production and calcium absorption during periods of increased calcium demands. Additional studies are needed to address PTH effects on bone modeling and remodeling during growth and development.
引用
收藏
页码:3814 / 3821
页数:8
相关论文
共 50 条
  • [41] Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue:: 19-nor-1,25-dihydroxyvitamin D2
    Llach, F
    Keshav, G
    Goldblat, MV
    Lindberg, JS
    Sadler, R
    Delmez, J
    Arruda, J
    Lau, A
    Slatopolsky, E
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (02) : S48 - S54
  • [42] High ratio of 1,25-dihydroxyvitamin D3 to parathyroid hormone in serum of tuberculous patients with end-stage renal-disease
    Yonemura, K
    Ohtake, T
    Matsushima, H
    Fujigaki, Y
    Hishida, A
    [J]. CLINICAL NEPHROLOGY, 2004, 62 (03) : 202 - 207
  • [43] The relationship of 1,25-dihydroxyvitamin D and Vitamin D binding protein in periodontitis
    Rafique, Sara
    Hingorjo, Mozaffer Rahim
    Mumtaz, Mahparah
    Qureshi, Masood Anwar
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2019, 35 (03) : 847 - 851
  • [44] Electromechanical Effects of 1,25-Dihydroxyvitamin D with Antiatrial Fibrillation Activities
    Hanafy, Dicky A.
    Chang, Shih-Lin
    Lu, Yen-Yu
    Chen, Yao-Chang
    Kao, Yu-Hsun
    Huang, Jen-Hung
    Chen, Shih-Ann
    Chen, Yi-Jen
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2014, 25 (03) : 317 - 323
  • [45] 1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma
    Rodriguez-Gutierrez, Rene
    Zapata-Rivera, Maria Azucena
    Quintanilla-Flores, Dania Lizeth
    Camara-Lemarroy, Carlos Rodrigo
    Lavalle-Gonzalez, Fernando Javier
    Gonzalez-Gonzalez, Jos Gerardo
    Villarreal-Perez, Jesus Zacarias
    [J]. BMC ENDOCRINE DISORDERS, 2014, 14
  • [46] Persistent and moderate hypercalcemia related to an ovarian clear cell adenocarcinoma: Pre- and postoperative parathyroid hormone related-peptide and 1,25-dihydroxyvitamin D3 levels
    A. Benit
    J. Allard
    J. Rimailho
    J. Fauvel
    G. Escourrou
    D. Vezzosi
    F. Donadille
    A. Bennet
    P. Caron
    [J]. Journal of Endocrinological Investigation, 2006, 29 : 443 - 449
  • [47] Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D
    Heikkinen, AM
    Parviainen, MT
    Tuppurainen, MT
    Niskanen, L
    Komulainen, MH
    Saarikoski, S
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1998, 62 (01) : 26 - 30
  • [48] Gender-Dependent Characteristics of Serum 1,25-Dihydroxyvitamin D/25-Hydroxyvitamin D Ratio for the Assessment of Bone Metabolism
    Fujita-Yamashita, Manami
    Yamamoto, Koichiro
    Honda, Hiroyuki
    Hanayama, Yoshihisa
    Tokumasu, Kazuki
    Nakano, Yasuhiro
    Hasegawa, Kou
    Hagiya, Hideharu
    Obika, Mikako
    Ogawa, Hiroko
    Otsuka, Fumio
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [49] Evaluation of a new automated assay for the measurement of circulating 1,25-dihydroxyvitamin D levels in daily practice
    Hussein, Hala
    Ibrahim, Fidaa
    Boudou, Philippe
    [J]. CLINICAL BIOCHEMISTRY, 2015, 48 (16-17) : 1160 - 1162
  • [50] PARATHYROID-HORMONE, 25-HYDROXYVITAMIN-D AND 1,25-DIHYDROXYVITAMIN-D CONCENTRATION IN ELDERLY PATIENTS
    OSTER, P
    MULLER, T
    SCHMIDTGAYK, H
    SCHLIERF, G
    [J]. KLINISCHE WOCHENSCHRIFT, 1990, 68 (08): : 421 - 426